05.16.13
Health Enhancement Products, Inc. (HEPI), headquartered in Michigan, investigates and licenses high-value bioactive molecules derived from algae that benefit human and animal health. The company has executed a formal partnership with the Arizona Center for Algae Technology and Innovation (AzCATI), located at the Arizona State University Polytechnic campus in Mesa, AZ,and the Algae Testbed Public-Private Partnership (ATP3).
AzCATI serves as a national test bed for research, testing, and commercialization of algae-based products. These include biofuels, pharmaceuticals, nutraceuticals, and other algae biomass co-products. AzCATI provides open test and evaluation facilities for the algae industry and research community. The center can assess the performance of individual and combined unit operations across the algal value chain.
AzCATI leads the ATP3 consortium with support from national labs and academic and industrial partners including the National Renewable Energy Laboratory (NREL), Sandia National Laboratories, Cellana LLC, Touchstone Research Laboratory, Valicor Renewables, Cal Poly San Luis Obispo, Georgia Institute of Technology, University of Texas at Austin, and Commercial Algae Management. ATP3 is funded by a $15 million competitive grant from the Bioenergy Technologies Office within the U.S. Department of Energy. The ATP3 collaborative is a network of regional test-beds designed to empower knowledge creation and dissemination within the algal research community, accelerate innovation, and support growth of the nascent algal fuels industry.
“These partnerships give us access to world-class algae experts and facilities,” said HEPI CEO Andrew Dahl. “Moving the cultures to the AzCATI/ ATP3site and to the NCMA labs opens up a vastly broader range of scientific capabilities and expertise and provides access to a tremendous network of development and production partners all while realizing substantial cost savings. The AzCATI/ATP3partnership in particular helps us accelerate the process of going to market.”
AzCATI serves as a national test bed for research, testing, and commercialization of algae-based products. These include biofuels, pharmaceuticals, nutraceuticals, and other algae biomass co-products. AzCATI provides open test and evaluation facilities for the algae industry and research community. The center can assess the performance of individual and combined unit operations across the algal value chain.
AzCATI leads the ATP3 consortium with support from national labs and academic and industrial partners including the National Renewable Energy Laboratory (NREL), Sandia National Laboratories, Cellana LLC, Touchstone Research Laboratory, Valicor Renewables, Cal Poly San Luis Obispo, Georgia Institute of Technology, University of Texas at Austin, and Commercial Algae Management. ATP3 is funded by a $15 million competitive grant from the Bioenergy Technologies Office within the U.S. Department of Energy. The ATP3 collaborative is a network of regional test-beds designed to empower knowledge creation and dissemination within the algal research community, accelerate innovation, and support growth of the nascent algal fuels industry.
“These partnerships give us access to world-class algae experts and facilities,” said HEPI CEO Andrew Dahl. “Moving the cultures to the AzCATI/ ATP3site and to the NCMA labs opens up a vastly broader range of scientific capabilities and expertise and provides access to a tremendous network of development and production partners all while realizing substantial cost savings. The AzCATI/ATP3partnership in particular helps us accelerate the process of going to market.”
